Kyndryl (KD) Financials

Kyndryl logo
$16.69 -0.12 (-0.73%)
Closing price 03:59 PM Eastern
Extended Trading
$16.66 -0.03 (-0.17%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Kyndryl

Annual Income Statements for Kyndryl

This table shows Kyndryl's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2022 2023 2024 2025 2026
Period end date 12/31/2019 12/31/2020 12/31/2021 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-943 -2,007 -2,304 -1,374 -340 252 198
Consolidated Net Income / (Loss)
-943 -2,007 -2,304 -1,374 -340 252 198
Net Income / (Loss) Continuing Operations
-943 -2,007 -2,305 -1,375 -340 251 199
Total Pre-Tax Income
-579 -1,760 -1,903 -851 -168 435 414
Total Operating Income
-503 -1,697 -1,800 -685 -47 536 562
Total Gross Profit
2,597 2,215 2,107 2,528 2,863 3,143 3,289
Total Revenue
20,279 19,352 18,657 17,026 16,052 15,057 15,092
Operating Revenue
20,279 19,352 18,657 17,026 16,052 15,057 15,092
Total Cost of Revenue
17,682 17,137 16,550 14,498 13,189 11,914 11,803
Operating Cost of Revenue
17,682 17,137 16,550 14,498 13,189 11,914 11,803
Total Operating Expenses
3,100 3,912 3,907 3,213 2,910 2,607 2,727
Selling, General & Admin Expense
2,970 2,948 2,776 2,914 2,773 2,591 2,654
Other Operating Expenses / (Income)
-29 943 35 35 183 141 32
Restructuring Charge
159 21 627 264 -46 -125 41
Total Other Income / (Expense), net
-76 -63 -103 -165 -122 -100 -149
Interest Expense
76 63 103 165 122 100 149
Income Tax Expense
364 247 402 524 172 184 215
Basic Earnings per Share
($4.21) ($8.96) ($10.28) ($6.06) ($1.48) $1.09 $0.87
Weighted Average Basic Shares Outstanding
224.10M 224.10M 224.10M 226.70M 229.20M 231.50M 228.30M
Diluted Earnings per Share
($4.21) ($8.96) ($10.28) ($6.06) ($1.48) $1.05 $0.85
Weighted Average Diluted Shares Outstanding
224.10M 224.10M 224.10M 226.70M 229.20M 239.10M 233.80M
Weighted Average Basic & Diluted Shares Outstanding
- - 224.54M 227.84M 230.51M 229.94M 219.92M
Cash Dividends to Common per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00

Quarterly Income Statements for Kyndryl

This table shows Kyndryl's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q1 2027 Q2 2027
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-142 -12 -45 11 -43 215 69 57 68 -54 59
Consolidated Net Income / (Loss)
-142 -12 -45 11 -43 215 69 56 68 -55 59
Net Income / (Loss) Continuing Operations
-142 -12 -45 11 -43 215 68 57 68 -54 59
Total Pre-Tax Income
-109 53 -3.00 64 -5.00 258 118 92 98 -69 112
Total Operating Income
-39 103 89 92 20 299 239 137 137 118 186
Total Gross Profit
651 752 716 805 750 763 825 796 801 776 857
Total Revenue
4,073 3,936 3,850 3,739 3,774 3,744 3,800 3,743 3,721 3,618 3,651
Operating Revenue
4,073 3,936 3,850 3,739 3,774 3,744 3,800 3,743 3,721 3,618 3,651
Total Cost of Revenue
3,422 3,184 3,134 2,934 3,024 2,981 2,975 2,947 2,920 2,842 2,794
Operating Cost of Revenue
3,422 3,184 3,134 2,934 3,024 2,981 2,975 2,947 2,920 2,842 2,794
Total Operating Expenses
690 649 627 713 730 464 586 659 664 658 671
Selling, General & Admin Expense
634 705 714 657 647 647 640 646 659 668 669
Other Operating Expenses / (Income)
8.00 21 -28 36 83 -35 -57 13 5.00 -10 -1.00
Impairment Charge
- - - - - - - 0.00 0.00 38 0.00
Restructuring Charge
48 -77 -59 20 0.00 -148 3.00 0.00 0.00 -38 3.00
Total Other Income / (Expense), net
-70 -50 -92 -28 -25 -41 -120 -44 -39 -186 -75
Interest Expense
70 50 92 28 25 41 120 44 39 186 75
Income Tax Expense
33 65 42 53 38 43 50 36 30 -14 53
Basic Earnings per Share
($0.62) ($0.05) ($0.19) $0.05 ($0.19) $0.93 $0.30 $0.24 $0.29 ($0.25) $0.27
Weighted Average Basic Shares Outstanding
229.10M 229.60M 229.20M 230.50M 231.60M 232.20M 231.50M 230.20M 230.60M 220.60M 218M
Diluted Earnings per Share
($0.62) ($0.05) ($0.19) $0.05 ($0.19) $0.89 $0.30 $0.23 $0.29 ($0.25) $0.27
Weighted Average Diluted Shares Outstanding
229.10M 229.60M 229.20M 235.80M 231.60M 240.70M 239.10M 239.10M 235.90M 220.60M 219.10M
Weighted Average Basic & Diluted Shares Outstanding
229.46M 230.10M 230.51M 231.21M 228.56M 225.45M 229.94M 231.14M - 217.82M 217.83M

Annual Cash Flow Statements for Kyndryl

This table details how cash moves in and out of Kyndryl's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2022 2023 2024 2025 2026
Period end date 12/31/2019 12/31/2020 12/31/2021 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Change in Cash & Equivalents
5.00 -13 2,203 -294 -306 235 836
Net Cash From Operating Activities
1,134 628 -119 781 454 942 948
Net Cash From Continuing Operating Activities
1,133 631 -117 784 454 940 948
Net Income / (Loss) Continuing Operations
-943 -2,007 -2,304 -1,374 -340 252 198
Consolidated Net Income / (Loss)
-943 -2,007 -2,304 -1,374 -340 252 198
Depreciation Expense
1,898 1,869 1,627 1,328 1,153 987 1,051
Amortization Expense
2,137 2,091 1,878 1,717 1,817 1,728 1,724
Non-Cash Adjustments To Reconcile Net Income
52 68 551 119 -161 -472 -477
Changes in Operating Assets and Liabilities, net
-2,011 -1,390 -1,869 -1,006 -2,015 -1,555 -1,548
Net Cash From Investing Activities
-1,128 -953 -572 -835 -553 -404 -561
Net Cash From Continuing Investing Activities
-1,129 -953 -572 -835 -553 -403 -561
Purchase of Property, Plant & Equipment
-1,190 -1,036 -752 -865 -651 -605 -608
Sale of Property, Plant & Equipment
63 84 194 23 138 83 65
Other Investing Activities, net
-2.00 -1.00 -14 7.00 -40 119 -18
Net Cash From Financing Activities
0.00 312 2,915 -141 -170 -286 457
Net Cash From Continuing Financing Activities
0.00 311 2,916 -141 -170 -286 457
Repayment of Debt
-18 -66 -91 -122 -642 -148 -145
Repurchase of Common Equity
- - - 0.00 0.00 -93 -304
Issuance of Debt
0.00 0.00 3,038 0.00 494 0.00 1,000
Other Financing Activities, net
18 377 -31 -19 -22 -45 -94
Effect of Exchange Rate Changes
-1.00 - -22 -100 -37 -16 -9.00
Cash Interest Paid
0.00 0.00 2.00 98 118 119 115
Cash Income Taxes Paid
0.00 0.00 12 167 191 149 151

Quarterly Cash Flow Statements for Kyndryl

This table details how cash moves in and out of Kyndryl's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q1 2027 Q2 2027
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-109 279 -137 -281 57 175 284 -323 -130 -515 -438
Net Cash From Operating Activities
46 436 145 -48 149 260 581 -124 146 -310 173
Net Cash From Continuing Operating Activities
46 435 146 -47 148 259 581 -125 147 -312 177
Net Income / (Loss) Continuing Operations
-142 -12 -45 11 -43 215 69 56 68 -55 59
Consolidated Net Income / (Loss)
-142 -12 -45 11 -43 215 69 56 68 -55 59
Depreciation Expense
303 286 263 197 233 261 296 264 267 251 260
Amortization Expense
456 460 430 424 445 442 417 421 437 431 433
Non-Cash Adjustments To Reconcile Net Income
19 -4.00 72 51 -16 -65 -22 -165 -77 -132 -93
Changes in Operating Assets and Liabilities, net
-590 -295 -574 -730 -471 -594 -179 -701 -548 -807 -482
Net Cash From Investing Activities
-95 -142 -203 -166 -75 42 -205 -74 -122 -49 -519
Net Cash From Continuing Investing Activities
-96 -141 -203 -166 -75 41 -203 -75 -119 -49 -519
Purchase of Property, Plant & Equipment
-175 -174 -202 -122 -134 -109 -240 -143 -129 -149 -214
Sale of Property, Plant & Equipment
113 15 4.00 24 30 16 13 45 6.00 58 8.00
Other Investing Activities, net
-34 18 -5.00 -68 29 88 24 23 4.00 42 -313
Net Cash From Financing Activities
-42 -43 -47 -51 -50 -71 -114 -170 -140 -152 -90
Net Cash From Continuing Financing Activities
-42 -43 -47 -51 -51 -70 -114 -170 -141 -152 -90
Repayment of Debt
-37 -36 -538 -44 -34 -32 -38 -41 -30 -75 -1,036
Repurchase of Common Equity
- - - 0.00 - - -63 -62 -89 -64 -33
Other Financing Activities, net
-5.00 -7.00 -3.00 -7.00 -17 -8.00 -13 -67 -22 -13 -7.00
Effect of Exchange Rate Changes
-18 28 -32 -17 34 -56 23 46 -16 -4.00 -2.00
Cash Interest Paid
13 49 10 40 20 40 19 39 19 50 39
Cash Income Taxes Paid
23 52 51 54 35 34 26 67 25 76 33

Annual Balance Sheets for Kyndryl

This table presents Kyndryl's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2022 2023 2024 2025 2026
Period end date 12/31/2020 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Total Assets
11,205 13,442 11,464 10,590 10,452 12,551
Total Current Assets
2,843 6,092 4,963 4,747 4,589 5,528
Cash & Equivalents
24 2,134 1,847 1,553 1,786 2,623
Restricted Cash
14 20 12 1.00 3.00 3.00
Accounts Receivable
1,444 2,271 1,523 1,599 1,345 1,300
Prepaid Expenses
157 525 510 514 446 436
Other Current Assets
1,205 1,143 1,070 1,081 1,009 1,166
Plant, Property, & Equipment, net
3,991 2,834 2,779 2,674 2,570 2,517
Total Noncurrent Assets
4,372 4,515 3,722 3,169 3,293 4,506
Goodwill
1,230 823 812 805 790 786
Intangible Assets
60 145 171 188 218 165
Noncurrent Deferred & Refundable Income Taxes
424 555 248 220 204 240
Employee Benefit Assets
1.00 61 94 105 148 222
Other Noncurrent Operating Assets
2,657 2,931 2,397 1,851 1,933 3,093
Total Liabilities & Shareholders' Equity
11,205 13,442 11,464 10,590 10,452 12,551
Total Liabilities
6,274 10,730 10,002 9,468 9,121 11,259
Total Current Liabilities
3,910 5,058 4,868 4,589 4,300 6,307
Short-Term Debt
69 96 110 126 129 1,796
Accounts Payable
919 1,555 1,774 1,408 1,351 1,346
Accrued Expenses
1,386 1,358 970 1,008 891 1,272
Current Deferred Revenue
854 882 820 825 746 888
Current Employee Benefit Liabilities
350 509 533 609 652 463
Other Taxes Payable
- 284 347 327 256 278
Other Current Liabilities
333 374 316 285 274 265
Total Noncurrent Liabilities
2,365 5,672 5,134 4,880 4,820 4,951
Long-Term Debt
140 3,127 3,111 3,112 3,042 2,293
Noncurrent Deferred Revenue
543 452 362 314 341 390
Noncurrent Employee Benefit Liabilities
550 716 504 500 483 490
Other Noncurrent Operating Liabilities
1,132 1,377 1,157 954 954 1,778
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,931 2,711 1,462 1,122 1,331 1,293
Total Preferred & Common Equity
4,873 2,618 1,365 1,015 1,219 1,175
Total Common Equity
4,872 2,617 1,365 1,015 1,220 1,176
Common Stock
0.00 4,315 4,428 4,524 4,631 4,701
Retained Earnings
0.00 -605 -1,978 -2,319 -2,067 -1,869
Treasury Stock
0.00 -4.00 -23 -45 -184 -582
Accumulated Other Comprehensive Income / (Loss)
-1,100 -1,089 -1,062 -1,145 -1,160 -1,074
Noncontrolling Interest
58 94 97 107 113 117

Quarterly Balance Sheets for Kyndryl

This table presents Kyndryl's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q1 2027 Q2 2027
Period end date 9/30/2022 12/31/2022 6/30/2023 9/30/2023 12/31/2023 6/30/2024 9/30/2025 12/31/2025 6/30/2025 6/30/2026 9/30/2026
Total Assets
11,629 11,851 10,986 10,602 10,969 10,163 11,244 11,276 11,495 12,026 11,866
Total Current Assets
4,964 4,967 4,653 4,593 4,851 4,355 4,291 4,325 4,468 5,069 4,588
Cash & Equivalents
1,888 2,002 1,507 1,408 1,688 1,269 1,331 1,348 1,462 2,104 1,659
Restricted Cash
12 14 14 3.00 2.00 5.00 5.00 4.00 4.00 6.00 13
Accounts Receivable
1,578 1,539 1,490 1,663 1,658 1,440 1,316 1,353 1,277 1,248 1,217
Prepaid Expenses
512 486 567 566 578 613 538 532 580 564 536
Other Current Assets
973 927 1,075 952 924 1,029 1,101 1,089 1,144 1,146 1,163
Plant, Property, & Equipment, net
2,592 2,762 2,750 2,646 2,806 2,690 2,628 2,621 2,634 2,477 2,533
Total Noncurrent Assets
4,072 4,122 3,583 3,364 3,313 3,117 4,324 4,330 4,393 4,480 4,744
Goodwill
811 812 807 806 809 786 791 787 793 784 918
Intangible Assets
139 158 187 188 192 222 168 167 168 161 327
Noncurrent Deferred & Refundable Income Taxes
481 478 190 186 208 207 227 281 222 248 253
Employee Benefit Assets
54 58 100 97 105 109 173 179 166 226 232
Other Noncurrent Operating Assets
2,587 2,616 2,299 2,087 1,999 1,793 2,965 2,916 3,044 3,061 3,014
Total Liabilities & Shareholders' Equity
11,629 11,851 10,986 10,602 10,969 10,163 11,244 11,276 11,495 12,026 11,866
Total Liabilities
9,882 9,920 9,648 9,489 9,676 9,062 9,904 9,967 10,151 10,859 10,689
Total Current Liabilities
4,579 4,607 4,591 4,485 5,152 4,231 4,197 5,043 4,242 5,980 4,816
Short-Term Debt
97 103 134 121 628 130 124 805 128 1,781 778
Accounts Payable
1,594 1,719 1,626 1,246 1,477 1,337 1,117 1,242 1,144 1,052 994
Accrued Expenses
1,042 1,006 907 1,137 1,107 969 1,094 1,255 1,103 1,350 1,267
Current Deferred Revenue
726 817 785 790 793 805 827 759 854 876 838
Current Employee Benefit Liabilities
534 388 473 609 559 414 459 370 437 415 474
Other Taxes Payable
264 - - 308 - 304 286 - 289 - 217
Other Current Liabilities
322 329 307 274 257 271 291 285 289 264 248
Total Noncurrent Liabilities
5,303 5,313 5,057 5,003 4,523 4,830 5,708 4,925 5,910 4,877 5,874
Long-Term Debt
3,101 3,097 3,149 3,123 2,629 3,109 3,004 2,295 3,014 2,289 3,281
Noncurrent Deferred Revenue
373 377 334 316 326 325 393 377 441 378 364
Noncurrent Employee Benefit Liabilities
625 660 501 481 493 492 513 544 517 489 487
Other Noncurrent Operating Liabilities
1,204 1,179 1,073 1,083 1,075 904 1,798 1,709 1,938 1,721 1,742
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,746 1,930 1,338 1,113 1,293 1,101 1,340 1,309 1,343 1,167 1,176
Total Preferred & Common Equity
1,650 1,832 1,240 1,013 1,189 996 1,227 1,194 1,234 1,070 1,077
Total Common Equity
1,650 1,832 1,239 1,012 1,190 996 1,228 1,194 1,234 1,070 1,077
Common Stock
4,370 4,397 4,451 4,476 4,501 4,549 4,686 4,710 4,656 4,722 4,744
Retained Earnings
-1,136 -1,241 -2,120 -2,262 -2,274 -2,308 -1,943 -1,886 -2,011 -1,924 -1,865
Treasury Stock
-17 -21 -30 -35 -42 -53 -427 -532 -317 -659 -699
Accumulated Other Comprehensive Income / (Loss)
-1,567 -1,303 -1,062 -1,167 -995 -1,192 -1,088 -1,098 -1,094 -1,069 -1,103
Noncontrolling Interest
96 99 99 100 104 105 112 115 110 97 99

Annual Metrics And Ratios for Kyndryl

This table displays calculated financial ratios and metrics derived from Kyndryl's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2021 3/31/2023 3/31/2024 3/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - 225,447,192.00
DEI Adjusted Shares Outstanding
- - - - - - - 225,447,192.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - 0.88
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% -4.57% -3.59% 0.00% -8.74% -5.72% -6.20% 0.23%
EBITDA Growth
0.00% -35.93% -24.66% 0.00% 34.25% 33.73% 9.93% 2.65%
EBIT Growth
0.00% -237.38% -6.07% 0.00% 58.00% 112.04% 614.29% 4.85%
NOPAT Growth
0.00% -237.38% -6.07% 0.00% 58.00% 112.04% 488.79% -12.65%
Net Income Growth
0.00% -112.83% -14.80% 0.00% 40.36% 75.25% 174.12% -21.43%
EPS Growth
0.00% -112.83% -14.73% 0.00% 41.05% 75.58% 170.95% -19.05%
Operating Cash Flow Growth
0.00% -44.62% -118.95% 0.00% 756.30% -41.87% 107.49% 0.64%
Free Cash Flow Firm Growth
0.00% 0.00% 101.32% -1,644.58% 133.60% -81.96% 501.10% -42.65%
Invested Capital Growth
0.00% 0.00% -26.32% 0.59% -25.39% -0.50% -3.28% 1.47%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% -2.94% -2.47% -0.33% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% -2.14% 9.09% 6.62% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 9.68% 133.96% 41.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 9.68% 133.96% 85.12% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% -21.49% 67.05% 82.61% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% -20.72% 67.33% 87.50% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 71.67% -114.60% 77.10% 41.43% 86.17% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 13.60% 190.81% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% -9.47% -1.85% -6.44% 0.00%
Profitability Metrics
- - - - - - - -
Gross Margin
12.81% 11.45% 11.29% 11.29% 14.85% 17.84% 20.87% 21.79%
EBITDA Margin
17.42% 11.69% 9.14% 9.14% 13.44% 19.07% 22.35% 22.11%
Operating Margin
-2.48% -8.77% -9.65% -9.65% -4.44% 0.57% 4.32% 3.72%
EBIT Margin
-2.48% -8.77% -9.65% -9.65% -4.44% 0.57% 4.32% 3.72%
Profit (Net Income) Margin
-4.65% -10.37% -12.35% -12.35% -8.07% -2.12% 1.67% 1.31%
Tax Burden Percent
162.87% 114.03% 121.07% 121.07% 161.46% 202.38% 57.93% 47.83%
Interest Burden Percent
115.11% 103.71% 105.72% 105.72% 112.57% -184.62% 66.92% 73.67%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 42.30% 51.93%
Return on Invested Capital (ROIC)
0.00% -46.57% -28.44% -33.42% -16.03% 2.26% 13.58% 9.88%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -1,004.58% -207.97% -134.68% -85.59% -24.26% 5.56% 4.81%
Return on Net Nonoperating Assets (RNNOA)
0.00% -34.84% -31.42% -53.16% -49.82% -28.58% 6.96% 5.21%
Return on Equity (ROE)
0.00% -81.40% -59.86% -86.58% -65.85% -26.32% 20.55% 15.09%
Cash Return on Invested Capital (CROIC)
0.00% -246.57% 1.87% -34.01% 13.05% 2.76% 16.92% 8.41%
Operating Return on Assets (OROA)
0.00% -15.15% -14.74% -13.39% -6.07% 0.83% 6.18% 4.89%
Return on Assets (ROA)
0.00% -17.91% -18.87% -17.14% -11.03% -3.08% 2.40% 1.72%
Return on Common Equity (ROCE)
0.00% -80.43% -59.39% -83.58% -62.84% -24.24% 18.72% 13.78%
Return on Equity Simple (ROE_SIMPLE)
0.00% -41.19% -83.33% -88.01% -100.66% -33.50% 20.67% 0.00%
Net Operating Profit after Tax (NOPAT)
-352 -1,188 -1,260 -1,260 -529 64 375 270
NOPAT Margin
-1.74% -6.14% -6.75% -6.75% -3.11% 0.40% 2.49% 1.79%
Net Nonoperating Expense Percent (NNEP)
0.00% 958.01% 179.54% 101.26% 69.56% 26.52% 8.02% 5.07%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - 8.33% 5.02%
Cost of Revenue to Revenue
87.19% 88.55% 88.71% 88.71% 85.15% 82.16% 79.13% 78.21%
SG&A Expenses to Revenue
14.65% 15.23% 14.88% 14.88% 17.12% 17.28% 17.21% 17.59%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
15.29% 20.22% 20.94% 20.94% 19.29% 17.27% 16.56% 18.07%
Earnings before Interest and Taxes (EBIT)
-503 -1,697 -1,800 -1,800 -756 91 650 562
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
3,532 2,263 1,705 1,705 2,289 3,061 3,365 3,337
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 1.47 1.55 2.46 4.93 5.99 2.52
Price to Tangible Book Value (P/TBV)
0.00 0.00 2.03 2.46 8.79 227.59 34.47 13.15
Price to Revenue (P/Rev)
0.00 0.00 0.22 0.22 0.20 0.31 0.49 0.20
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 28.99 14.94
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.45% 6.69%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.34 1.38 1.71 2.42 3.24 1.65
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.27 0.28 0.28 0.42 0.58 0.30
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 2.96 3.06 2.10 2.22 2.62 1.36
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 74.70 13.54 8.07
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 106.72 23.47 16.80
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 6.17 14.97 9.34 4.79
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 60.87 0.00 11.18 87.49 18.84 19.72
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.00 0.04 1.17 1.19 2.20 2.89 2.38 3.16
Long-Term Debt to Equity
0.00 0.03 1.13 1.15 2.13 2.77 2.29 1.77
Financial Leverage
0.00 0.03 0.15 0.39 0.58 1.18 1.25 1.08
Leverage Ratio
0.00 2.27 3.17 4.96 5.97 8.53 8.58 8.77
Compound Leverage Factor
0.00 2.36 3.35 5.24 6.72 -15.76 5.74 6.46
Debt to Total Capital
0.00% 4.07% 53.88% 54.31% 68.78% 74.27% 70.44% 75.98%
Short-Term Debt to Total Capital
0.00% 1.34% 1.75% 1.62% 2.35% 2.89% 2.87% 33.37%
Long-Term Debt to Total Capital
0.00% 2.72% 52.13% 52.70% 66.43% 71.38% 67.57% 42.61%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 1.13% 0.05% 1.58% 2.07% 2.45% 2.51% 2.17%
Common Equity to Total Capital
0.00% 94.79% 46.08% 44.10% 29.15% 23.28% 27.10% 21.85%
Debt to EBITDA
0.00 0.09 1.90 1.89 1.41 1.06 0.94 1.23
Net Debt to EBITDA
0.00 0.08 0.58 0.63 0.60 0.55 0.41 0.44
Long-Term Debt to EBITDA
0.00 0.06 1.83 1.83 1.36 1.02 0.90 0.69
Debt to NOPAT
0.00 -0.18 -2.57 -2.56 -6.09 50.83 8.45 15.14
Net Debt to NOPAT
0.00 -0.14 -0.79 -0.85 -2.57 26.44 3.68 5.42
Long-Term Debt to NOPAT
0.00 -0.12 -2.48 -2.48 -5.88 48.85 8.11 8.49
Altman Z-Score
0.00 0.00 1.28 1.20 1.24 1.57 1.88 1.22
Noncontrolling Interest Sharing Ratio
0.00% 1.20% 0.79% 3.47% 4.58% 7.89% 8.89% 8.69%
Liquidity Ratios
- - - - - - - -
Current Ratio
0.00 0.73 1.30 1.20 1.02 1.03 1.07 0.88
Quick Ratio
0.00 0.38 1.01 0.87 0.69 0.69 0.73 0.62
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -6,290 83 -1,282 431 78 467 230
Operating Cash Flow to CapEx
100.62% 65.97% -21.33% -21.33% 92.76% 88.50% 180.46% 174.59%
Free Cash Flow to Firm to Interest Expense
0.00 -99.84 0.81 -12.45 4.58 0.30 2.18 1.54
Operating Cash Flow to Interest Expense
14.92 9.97 -1.16 -1.16 8.31 1.75 4.40 6.36
Operating Cash Flow Less CapEx to Interest Expense
0.09 -5.14 -6.57 -6.57 -0.65 -0.23 1.96 2.72
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.00 1.73 1.53 1.39 1.37 1.46 1.43 1.31
Accounts Receivable Turnover
0.00 13.40 10.02 8.22 8.98 10.28 10.23 11.41
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 4.85 5.40 6.58 6.07 5.89 5.74 5.93
Accounts Payable Turnover
0.00 18.65 16.08 10.64 8.71 8.29 8.64 8.75
Days Sales Outstanding (DSO)
0.00 27.24 36.42 44.43 40.67 35.50 35.68 31.98
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 19.57 22.71 34.29 41.91 44.03 42.26 41.70
Cash Conversion Cycle (CCC)
0.00 7.66 13.71 10.13 -1.24 -8.54 -6.58 -9.72
Capital & Investment Metrics
- - - - - - - -
Invested Capital
0.00 5,102 3,759 3,781 2,821 2,807 2,715 2,755
Invested Capital Turnover
0.00 7.59 4.21 4.95 5.16 5.70 5.45 5.52
Increase / (Decrease) in Invested Capital
0.00 5,102 -1,343 22 -960 -14 -92 40
Enterprise Value (EV)
0.00 0.00 5,052 5,220 4,817 6,798 8,802 4,538
Market Capitalization
0.00 0.00 4,056 4,057 3,358 5,007 7,307 2,958
Book Value per Share
$0.00 $21.74 $12.34 $11.68 $6.00 $4.41 $5.24 $5.22
Tangible Book Value per Share
$0.00 $15.98 $8.91 $7.36 $1.68 $0.10 $0.91 $1.00
Total Capital
0.00 5,140 6,000 5,934 4,683 4,360 4,502 5,382
Total Debt
0.00 209 3,233 3,223 3,221 3,238 3,171 4,089
Total Long-Term Debt
0.00 140 3,128 3,127 3,111 3,112 3,042 2,293
Net Debt
0.00 171 993 1,069 1,362 1,684 1,382 1,463
Capital Expenditures (CapEx)
1,127 952 558 558 842 513 522 543
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -1,036 -815 -1,024 -1,654 -1,270 -1,371 -1,609
Debt-free Net Working Capital (DFNWC)
0.00 -998 1,425 1,130 205 284 418 1,017
Net Working Capital (NWC)
0.00 -1,067 1,320 1,034 95 158 289 -779
Net Nonoperating Expense (NNE)
591 819 1,044 1,044 845 404 123 72
Net Nonoperating Obligations (NNO)
0.00 171 992 1,070 1,359 1,685 1,384 1,462
Total Depreciation and Amortization (D&A)
4,035 3,960 3,505 3,505 3,045 2,970 2,715 2,775
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -5.35% -4.37% -5.49% -9.71% -7.91% -9.11% -10.66%
Debt-free Net Working Capital to Revenue
0.00% -5.16% 7.64% 6.06% 1.20% 1.77% 2.78% 6.74%
Net Working Capital to Revenue
0.00% -5.51% 7.08% 5.54% 0.56% 0.98% 1.92% -5.16%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($10.35) ($10.35) ($6.06) ($1.48) $1.09 $0.87
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 224.10M 224.10M 226.70M 229.20M 231.50M 228.30M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($10.35) ($10.35) ($6.06) ($1.48) $1.05 $0.85
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 224.10M 224.10M 226.70M 229.20M 239.10M 233.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 224.54M 224.54M 227.84M 230.51M 229.94M 219.92M
Normalized Net Operating Profit after Tax (NOPAT)
-241 -1,173 -493 -493 -344 32 303 422
Normalized NOPAT Margin
-1.19% -6.06% -2.64% -2.64% -2.02% 0.20% 2.01% 2.80%
Pre Tax Income Margin
-2.86% -9.09% -10.20% -10.20% -5.00% -1.05% 2.89% 2.74%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
-6.62 -26.94 -17.48 -17.48 -8.04 0.35 3.04 3.77
NOPAT to Interest Expense
-4.63 -18.86 -12.23 -12.23 -5.63 0.25 1.75 1.81
EBIT Less CapEx to Interest Expense
-21.45 -42.05 -22.89 -22.89 -17.00 -1.62 0.60 0.13
NOPAT Less CapEx to Interest Expense
-19.46 -33.97 -17.65 -17.65 -14.59 -1.73 -0.69 -1.83
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 36.90% 153.54%

Quarterly Metrics And Ratios for Kyndryl

This table displays calculated financial ratios and metrics derived from Kyndryl's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q1 2027 Q2 2027
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 231,143,968.00 219,918,196.00 217,818,263.00
DEI Adjusted Shares Outstanding
- - - - - - - - 231,143,968.00 219,918,196.00 217,818,263.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.29 -0.25 0.27
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-2.54% -8.53% -9.54% -10.83% -7.34% -4.88% -1.30% 0.11% 0.00% -3.34% -1.88%
EBITDA Growth
33.58% 25.78% 48.39% -4.81% -3.06% 18.02% 28.13% 11.78% 3.19% -2.68% 4.52%
EBIT Growth
80.60% 200.98% 132.96% 500.00% 151.28% 190.29% 378.00% 21.74% 0.00% -13.87% 35.77%
NOPAT Growth
80.60% 67.34% 132.96% 198.21% 151.28% 1,168.43% 293.51% 331.14% 0.00% -0.95% 3.07%
Net Income Growth
49.47% 88.68% 93.89% 107.80% 69.72% 1,891.67% 253.33% 409.09% 0.00% -198.21% -13.24%
EPS Growth
50.00% 89.36% 94.14% 108.06% 69.35% 1,880.00% 257.89% 360.00% 0.00% -208.70% -6.90%
Operating Cash Flow Growth
-88.11% 56.83% 1,108.33% 72.25% 223.91% -40.37% 300.69% -158.33% 108.57% -150.00% 18.49%
Free Cash Flow Firm Growth
102.16% -59.29% -90.10% -88.25% -277.58% -10.96% 368.83% 151.34% 3,808.43% -122.45% -207.44%
Invested Capital Growth
-3.15% -8.22% -0.50% -1.03% 4.61% 1.47% -3.28% -1.69% 0.00% 3.75% 0.00%
Revenue Q/Q Growth
-2.86% -3.36% -2.19% -2.88% 0.94% -0.79% 1.50% -1.50% -0.59% 0.00% 0.91%
EBITDA Q/Q Growth
-3.87% 17.92% -7.89% -8.82% -2.10% 43.55% -4.99% -16.28% 2.31% 0.00% 9.88%
EBIT Q/Q Growth
-69.57% 364.10% -13.59% 3.37% -78.26% 1,395.00% -20.07% -53.14% 0.00% 0.00% 57.63%
NOPAT Q/Q Growth
-69.57% 14.58% 367.14% -74.62% -11.46% 1,679.76% -44.72% -50.50% 13.99% 0.00% 18.62%
Net Income Q/Q Growth
-0.71% 91.55% -275.00% 124.44% -490.91% 600.00% -67.91% -18.84% 21.43% 0.00% 207.27%
EPS Q/Q Growth
0.00% 91.94% -280.00% 126.32% -480.00% 568.42% -66.29% -23.33% 26.09% 0.00% 208.00%
Operating Cash Flow Q/Q Growth
126.59% 847.83% -66.74% -133.10% 410.42% 74.50% 123.46% -121.34% 217.74% 0.00% 155.81%
Free Cash Flow Firm Q/Q Growth
-83.12% 238.69% -67.21% -37.34% -355.16% 269.81% 10.89% -47.69% 2,281.29% 0.00% -11,294.80%
Invested Capital Q/Q Growth
-4.94% -2.95% -1.85% 9.30% 0.49% -5.87% -6.44% 11.09% -100.00% 0.00% 13.84%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
15.98% 19.11% 18.60% 21.53% 19.87% 20.38% 21.71% 21.27% 21.53% 21.45% 23.47%
EBITDA Margin
17.68% 21.57% 20.31% 19.07% 18.50% 26.76% 25.05% 21.29% 22.60% 22.11% 24.08%
Operating Margin
-0.96% 2.62% 2.31% 2.46% 0.53% 7.99% 6.29% 2.99% 3.68% 3.26% 5.09%
EBIT Margin
-0.96% 2.62% 2.31% 2.46% 0.53% 7.99% 6.29% 2.99% 3.68% 3.26% 5.09%
Profit (Net Income) Margin
-3.49% -0.30% -1.17% 0.29% -1.14% 5.74% 1.82% 1.50% 1.83% -1.52% 1.62%
Tax Burden Percent
130.28% -22.64% 1,500.00% 17.19% 860.00% 83.33% 58.47% 60.87% 69.39% 79.71% 52.68%
Interest Burden Percent
279.49% 51.46% -3.37% 69.57% -25.00% 86.29% 49.37% 82.14% 71.53% -58.47% 60.22%
Effective Tax Rate
0.00% 122.64% 0.00% 82.81% 0.00% 16.67% 42.37% 39.13% 30.61% 0.00% 47.32%
Return on Invested Capital (ROIC)
-3.77% -3.26% 9.23% 2.14% 1.88% 34.90% 19.77% 9.02% 0.00% 11.12% 22.45%
ROIC Less NNEP Spread (ROIC-NNEP)
-11.09% -2.44% 2.18% 1.88% -1.16% 32.80% 15.29% 8.35% 0.00% 3.55% 19.18%
Return on Net Nonoperating Assets (RNNOA)
-12.15% -2.09% 2.57% 2.88% -1.90% 42.89% 19.13% 12.43% 0.00% 5.14% 38.91%
Return on Equity (ROE)
-15.91% -5.35% 11.80% 5.01% -0.02% 77.79% 38.89% 21.45% 0.00% 16.26% 61.36%
Cash Return on Invested Capital (CROIC)
-6.94% 3.20% 2.76% -250.12% -11.69% 5.57% 16.92% 15.79% 0.00% 2.47% -190.17%
Operating Return on Assets (OROA)
-1.45% 3.77% 3.37% 3.63% 0.77% 11.55% 9.00% 4.16% 0.00% 4.15% 6.40%
Return on Assets (ROA)
-5.28% -0.44% -1.70% 0.43% -1.66% 8.30% 2.60% 2.08% 0.00% -1.93% 2.03%
Return on Common Equity (ROCE)
-14.82% -5.02% 10.87% 4.60% -0.02% 71.16% 35.44% 19.57% 0.00% 14.93% 56.20%
Return on Equity Simple (ROE_SIMPLE)
-111.16% -86.80% 0.00% -18.88% -8.36% 12.61% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-27 -23 62 16 14 249 138 68 95 83 98
NOPAT Margin
-0.67% -0.59% 1.62% 0.42% 0.37% 6.66% 3.62% 1.82% 2.55% 2.28% 2.68%
Net Nonoperating Expense Percent (NNEP)
7.33% -0.82% 7.05% 0.26% 3.04% 2.09% 4.48% 0.67% 0.00% 7.57% 3.27%
Return On Investment Capital (ROIC_SIMPLE)
- -0.51% - - - 5.66% 3.06% 1.52% - 1.58% 1.87%
Cost of Revenue to Revenue
84.02% 80.89% 81.40% 78.47% 80.13% 79.62% 78.29% 78.73% 78.47% 78.55% 76.53%
SG&A Expenses to Revenue
15.57% 17.91% 18.55% 17.57% 17.14% 17.28% 16.84% 17.26% 17.71% 18.46% 18.32%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
16.94% 16.49% 16.29% 19.07% 19.34% 12.39% 15.42% 18.27% 17.84% 18.19% 18.38%
Earnings before Interest and Taxes (EBIT)
-39 103 89 92 20 299 239 112 137 118 186
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
720 849 782 713 698 1,002 952 797 841 800 879
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.42 4.01 4.93 6.09 4.99 7.35 5.99 7.82 0.00 2.32 2.28
Price to Tangible Book Value (P/TBV)
192.02 25.23 227.59 0.00 110.69 91.32 34.47 35.34 0.00 19.90 0.00
Price to Revenue (P/Rev)
0.21 0.29 0.31 0.39 0.35 0.53 0.49 0.64 0.46 0.17 0.16
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 58.24 28.99 32.38 23.29 28.59 31.44
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 1.72% 3.45% 3.09% 4.29% 3.50% 3.18%
Enterprise Value to Invested Capital (EV/IC)
1.83 2.25 2.42 2.65 2.38 3.39 3.24 3.79 0.00 1.45 1.39
Enterprise Value to Revenue (EV/Rev)
0.32 0.39 0.42 0.52 0.48 0.65 0.58 0.76 0.00 0.30 0.33
Enterprise Value to EBITDA (EV/EBITDA)
2.02 2.26 2.22 2.69 2.44 3.12 2.62 3.32 0.00 1.37 1.47
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 74.70 39.49 27.66 21.35 13.54 17.07 0.00 8.37 8.34
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 106.72 0.00 0.00 48.58 23.47 26.70 0.00 24.06 28.19
Enterprise Value to Operating Cash Flow (EV/OCF)
33.06 20.06 14.97 14.05 10.75 19.45 9.34 13.20 0.00 5.96 6.26
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 67.29 87.49 0.00 0.00 61.28 18.84 23.81 0.00 59.90 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.91 2.52 2.89 2.94 2.77 2.66 2.38 2.34 0.00 3.49 3.45
Long-Term Debt to Equity
2.81 2.03 2.77 2.82 2.65 2.55 2.29 2.24 0.00 1.96 2.79
Financial Leverage
1.10 0.85 1.18 1.53 1.64 1.31 1.25 1.49 0.00 1.45 2.03
Leverage Ratio
7.78 7.08 8.53 8.67 9.19 8.37 8.58 8.86 0.00 9.37 10.09
Compound Leverage Factor
21.73 3.64 -0.29 6.03 -2.30 7.22 4.24 7.28 0.00 -5.48 6.08
Debt to Total Capital
74.45% 71.58% 74.27% 74.63% 73.44% 72.67% 70.44% 70.06% 0.00% 77.72% 77.54%
Short-Term Debt to Total Capital
2.78% 13.80% 2.89% 3.00% 3.06% 2.93% 2.87% 2.85% 0.00% 34.01% 14.86%
Long-Term Debt to Total Capital
71.68% 57.78% 71.38% 71.64% 70.38% 69.74% 67.57% 67.20% 0.00% 43.71% 62.67%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.30% 2.29% 2.45% 2.42% 2.42% 2.50% 2.51% 2.45% 0.00% 1.85% 1.89%
Common Equity to Total Capital
23.23% 26.15% 23.28% 22.95% 24.13% 24.84% 27.10% 27.51% 0.00% 20.43% 20.57%
Debt to EBITDA
1.21 1.14 1.06 1.07 1.08 1.01 0.94 0.91 0.00 1.23 1.21
Net Debt to EBITDA
0.69 0.55 0.55 0.65 0.64 0.54 0.41 0.49 0.00 0.59 0.71
Long-Term Debt to EBITDA
1.17 0.92 1.02 1.03 1.03 0.97 0.90 0.87 0.00 0.69 0.98
Debt to NOPAT
-10.68 -20.32 50.83 -0.42 -14.98 15.80 8.45 7.34 0.00 21.55 23.17
Net Debt to NOPAT
-6.03 -9.78 26.44 -0.25 -8.83 8.37 3.68 3.91 0.00 10.38 13.63
Long-Term Debt to NOPAT
-10.28 -16.40 48.85 -0.40 -14.35 15.16 8.11 7.04 0.00 12.12 18.73
Altman Z-Score
1.51 1.50 1.57 1.66 1.52 1.92 1.75 1.69 0.00 1.10 1.20
Noncontrolling Interest Sharing Ratio
6.89% 6.24% 7.89% 8.36% 9.10% 8.53% 8.89% 8.76% 0.00% 8.21% 8.42%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.02 0.94 1.03 1.03 1.03 1.09 1.07 1.05 0.00 0.85 0.95
Quick Ratio
0.68 0.65 0.69 0.64 0.65 0.73 0.73 0.65 0.00 0.56 0.60
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
69 233 76 48 -122 207 230 120 3,224 -30 -3,464
Operating Cash Flow to CapEx
74.19% 274.21% 73.23% -48.98% 143.27% 279.57% 255.95% -126.53% 118.70% -340.66% 83.98%
Free Cash Flow to Firm to Interest Expense
0.98 4.65 0.83 1.71 -4.88 5.05 1.91 6.32 82.67 -0.16 -46.19
Operating Cash Flow to Interest Expense
0.66 8.72 1.58 -1.71 5.96 6.34 4.84 -6.53 3.74 -1.67 2.31
Operating Cash Flow Less CapEx to Interest Expense
-0.23 5.54 -0.58 -5.21 1.80 4.07 2.95 -11.68 0.59 -2.16 -0.44
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.51 1.44 1.46 1.48 1.46 1.45 1.43 1.39 0.00 1.27 1.26
Accounts Receivable Turnover
10.38 10.30 10.28 10.65 9.86 9.97 10.23 11.09 0.00 11.86 12.24
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
6.42 5.91 5.89 5.73 5.69 5.71 5.74 5.66 0.00 5.86 5.88
Accounts Payable Turnover
9.91 8.55 8.29 8.55 9.88 9.20 8.64 9.61 0.00 10.65 11.64
Days Sales Outstanding (DSO)
35.16 35.45 35.50 34.28 37.03 36.63 35.68 32.92 0.00 30.79 29.82
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
36.81 42.68 44.03 42.67 36.96 39.67 42.26 37.96 0.00 34.26 31.35
Cash Conversion Cycle (CCC)
-1.66 -7.23 -8.54 -8.38 0.07 -3.04 -6.58 -5.04 0.00 -3.47 -1.53
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,947 2,860 2,807 3,068 3,083 2,902 2,715 3,016 0.00 3,129 3,562
Invested Capital Turnover
5.62 5.51 5.70 5.06 5.07 5.24 5.45 4.95 0.00 4.87 8.36
Increase / (Decrease) in Invested Capital
-96 -256 -14 -32 136 42 -92 -52 -3,129 113 3,562
Enterprise Value (EV)
5,389 6,439 6,798 8,135 7,331 9,842 8,802 11,434 0.00 4,544 4,939
Market Capitalization
3,456 4,768 5,007 6,065 5,313 8,037 7,307 9,648 6,941 2,487 2,453
Book Value per Share
$4.42 $5.19 $4.41 $4.32 $4.61 $4.71 $5.24 $5.37 $0.00 $4.87 $4.94
Tangible Book Value per Share
$0.08 $0.82 $0.10 ($0.05) $0.21 $0.38 $0.91 $1.19 $0.00 $0.57 ($0.77)
Total Capital
4,357 4,550 4,360 4,340 4,413 4,405 4,502 4,485 0.00 5,237 5,235
Total Debt
3,244 3,257 3,238 3,239 3,241 3,201 3,171 3,142 0.00 4,070 4,059
Total Long-Term Debt
3,123 2,629 3,112 3,109 3,106 3,072 3,042 3,014 0.00 2,289 3,281
Net Debt
1,833 1,567 1,684 1,965 1,911 1,695 1,382 1,676 0.00 1,960 2,387
Capital Expenditures (CapEx)
62 159 198 98 104 93 227 98 123 91 206
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1,182 -1,363 -1,270 -1,020 -1,057 -1,015 -1,371 -1,112 0.00 -1,240 -1,122
Debt-free Net Working Capital (DFNWC)
229 327 284 254 273 491 418 354 0.00 870 550
Net Working Capital (NWC)
108 -301 158 124 138 362 289 226 0.00 -911 -228
Net Nonoperating Expense (NNE)
115 -11 107 4.81 57 34 69 12 27 138 39
Net Nonoperating Obligations (NNO)
1,834 1,567 1,685 1,967 1,911 1,698 1,384 1,673 0.00 1,962 2,386
Total Depreciation and Amortization (D&A)
759 746 693 621 678 703 713 685 704 682 693
Debt-free, Cash-free Net Working Capital to Revenue
-7.03% -8.28% -7.91% -6.54% -6.91% -6.72% -9.11% -7.38% 0.00% -8.28% -7.53%
Debt-free Net Working Capital to Revenue
1.36% 1.99% 1.77% 1.63% 1.78% 3.25% 2.78% 2.35% 0.00% 5.81% 3.69%
Net Working Capital to Revenue
0.64% -1.83% 0.98% 0.80% 0.90% 2.40% 1.92% 1.50% 0.00% -6.09% -1.53%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.62) ($0.05) ($0.19) $0.05 ($0.19) $0.93 $0.30 $0.24 $0.00 ($0.25) $0.27
Adjusted Weighted Average Basic Shares Outstanding
229.10M 229.60M 229.20M 230.50M 231.60M 232.20M 231.50M 230.20M 0.00 220.60M 218M
Adjusted Diluted Earnings per Share
($0.62) ($0.05) ($0.19) $0.05 ($0.19) $0.89 $0.30 $0.23 $0.00 ($0.25) $0.27
Adjusted Weighted Average Diluted Shares Outstanding
229.10M 229.60M 229.20M 235.80M 231.60M 240.70M 239.10M 239.10M 0.00 220.60M 219.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
229.46M 230.10M 230.51M 231.21M 232.27M 232.69M 229.94M 231.14M 0.00 217.82M 217.83M
Normalized Net Operating Profit after Tax (NOPAT)
6.30 18 21 78 14 126 139 68 95 83 100
Normalized NOPAT Margin
0.15% 0.46% 0.55% 2.10% 0.37% 3.36% 3.67% 1.82% 2.55% 2.28% 2.73%
Pre Tax Income Margin
-2.68% 1.35% -0.08% 1.71% -0.13% 6.89% 3.11% 2.46% 2.63% -1.91% 3.07%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-0.56 2.06 0.97 3.29 0.80 7.29 1.99 5.89 3.51 0.63 2.48
NOPAT to Interest Expense
-0.39 -0.47 0.68 0.56 0.56 6.08 1.15 3.59 2.44 0.44 1.31
EBIT Less CapEx to Interest Expense
-1.44 -1.12 -1.18 -0.21 -3.36 5.02 0.10 0.74 0.36 0.15 -0.27
NOPAT Less CapEx to Interest Expense
-1.28 -3.65 -1.48 -2.94 -3.60 3.81 -0.74 -1.57 -0.72 -0.05 -1.44
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 36.90% 52.19% 82.15% 351.72% 320.51%

Financials Breakdown Chart

Key Financial Trends

Kyndryl’s financial profile shows meaningful operational improvement from its loss-heavy 2022 period, but the latest quarter raises concerns about revenue growth, interest costs and cash conversion. Revenue declined from $4.56 billion in Q3 2022 to $3.62 billion in Q1 2027, a decrease of roughly 21%. However, profitability has improved substantially: operating income was $118 million in the latest quarter compared with operating losses in several earlier periods, including a $702 million loss in Q3 2022.

Gross-margin performance has also strengthened. Kyndryl generated $776 million of gross profit in Q1 2027, representing a margin of approximately 21.5%, compared with about 12.2% in Q3 2022. Selling, general and administrative expense has generally declined from the $700 million-plus range in 2022 and early 2023 to $668 million most recently, although cost reductions have not yet translated into consistent net profitability.

The latest quarter was weaker on a year-over-year basis. Revenue fell 3.3% from $3.74 billion in Q1 2026, operating income declined from $137 million to $118 million, and Kyndryl swung from a $56 million consolidated profit to a $55 million loss. The main pressure was interest expense, which increased sharply to $186 million from $44 million.

  • Operating profitability has improved significantly. Kyndryl reported $118 million of operating income in Q1 2027, compared with operating losses in multiple earlier quarters.
  • Gross margins are substantially better. The latest gross margin was approximately 21.5%, well above the roughly 12% reported in Q3 2022.
  • SG&A remains below historical levels. Selling, general and administrative expense was $668 million in Q1 2027, below the $783 million reported in Q4 2023 and the $720 million reported in Q1 2024.
  • Cash and equivalents have increased over the longer term. Cash rose to $2.10 billion at June 30, 2026, from $1.51 billion at June 30, 2023, providing a meaningful liquidity reserve despite the latest quarterly cash decline.
  • Share repurchases have reduced the share count. Weighted-average basic shares declined to 220.6 million in Q1 2027 from 230.5 million in Q1 2024, which can support per-share results when earnings recover.
  • Large depreciation and amortization charges materially affect cash-flow comparisons. Q1 2027 included $682 million of combined depreciation and amortization, meaning reported net income understates the cash contribution of the operating business but also highlights the company’s sizable asset and acquisition-related cost base.
  • Capital spending remains significant but manageable. Kyndryl spent $149 million on property and equipment in Q1 2027, slightly above the prior-year period, while total investing cash outflow improved to $49 million from $74 million.
  • Revenue remains on a declining trend. Quarterly revenue has fallen from more than $4.5 billion in late 2022 to $3.62 billion in Q1 2027, and the latest year-over-year decline suggests that margin improvement is occurring alongside a smaller revenue base.
  • Operating cash flow turned sharply negative. Kyndryl generated negative $310 million of operating cash flow in Q1 2027 versus negative $124 million in Q1 2026. A $807 million use of cash from operating assets and liabilities was the primary driver.
  • Debt and liquidity metrics have become less comfortable. Short- and long-term debt totaled approximately $4.07 billion at June 30, 2026, while current liabilities of $5.98 billion exceeded current assets of $5.07 billion. The resulting current ratio of roughly 0.85, combined with a $186 million quarterly interest expense, leaves less room for operational setbacks.

For investors, the central question is whether Kyndryl can convert its improved gross and operating margins into recurring positive net income and operating cash flow. The company has made progress in restructuring its cost base, but continued revenue contraction, elevated interest expense and working-capital cash usage remain important risks to monitor.

11/16/26 05:27 PM ETAI Generated. May Contain Errors.

Kyndryl Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Kyndryl's fiscal year ends in March. Their fiscal year 2026 ended on March 31, 2026.

Kyndryl's net income appears to be on an upward trend, with a most recent value of $198 million in 2026, compared with -$943 million in 2019. The previous period was $252 million in 2025. See Kyndryl's forecast for analyst expectations on what's next for the company.

Kyndryl's total operating income in 2026 was $562 million, based on the following breakdown:
  • Total Gross Profit: $3.29 billion
  • Total Operating Expenses: $2.73 billion

Over the last 7 years, Kyndryl's total revenue changed from $20.28 billion in 2019 to $15.09 billion in 2026, a change of -25.6%.

In the past 16 quarters, Kyndryl's cash and equivalents has ranged from $1.27 billion in Q1 2025 to $2.10 billion in Q1 2027, and is currently $1.66 billion as of their latest financial filing in Q2 2027.

Kyndryl had total debt of $4.09 billion at the end of 2026, a 28.9% increase from 2025, and none in 2019.

Over the last 7 years, Kyndryl's book value per share changed from 0.00 in 2019 to 5.22 in 2026, a change of 521.6%.



Financial statements for NYSE:KD last updated on 11/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners